Earnings Feed
Start Free
$BAX·4

BAXTER INTERNATIONAL INC · Jul 6, 7:13 PM ET

BAXTER INTERNATIONAL INC 4

4 · BAXTER INTERNATIONAL INC · Filed Jul 6, 2015

Insider Transaction Report

Form 4
Period: 2015-07-01
BAXTER INTERNATIONAL INCBAX
Schabacker Marcus
CVP, Chief Scientific Officer
Transactions
  • Other

    Stock Option (Right to Buy)

    2015-07-01+43,596→ 94,461 total
    Exercise: $37.38Exp: 2025-03-03→ Common Stock, par value $1 per share (43,596 underlying)
  • Other

    Common Stock, par value $1 per share

    2015-07-01+6,311→ 24,459 total
  • Award

    Common Stock, par value $1 per share

    2015-07-01+5,000→ 29,459 total
Holdings

  • Stock Option (Right to Buy)

    Exercise: $37.17Exp: 2024-03-04→ Common Stock, par value $1 per share (28,761 underlying)
    28,761

  • Stock Option (Right to Buy)

    Exercise: $37.82Exp: 2023-03-05→ Common Stock, par value $1 per share (27,062 underlying)
    27,062
Footnotes (7)
  • [F1]In connection with the spin-off (the "Spin-off") of Baxalta Incorporated ("Baxalta") from Baxter International Inc. ("Baxter"), the reporting person received a grant of 6,311 restricted stock units as a result of the adjustment of existing Baxter restricted stock units held by the reporting person prior to the Spin-off. These restricted stock units will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date.
  • [F2]The reporting person received a grant of 5,000 restricted stock units which will vest on July 1, 2018.
  • [F3]Represents options to purchase Baxter common stock awarded to the reporting person prior to the Spin-off. In connection with the Spin-off, the exercise price of the option was adjusted, and the reporting person received options to purchase shares of Baxalta common stock, to preserve the pre-Spin-off intrinsic value of the existing Baxter option award.
  • [F4]Two-thirds of this option is presently exercisable. The remaining one third becomes exercisable on March 5, 2016.
  • [F5]One-third of this option is presently exercisable. The remaining two thirds become exercisable on March 4, 2016 and March 4, 2017.
  • [F6]In connection with the Spin-off, the number of shares subject to this option and the exercise price have been adjusted to preserve the pre-Spin-off intrinsic value of the existing Baxter option award.
  • [F7]This option will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date of the existing option award.

Documents

2 files